Company · founded 2015

Aeolis Research (United States)

Pasadena, United States · aeolisresearch.com

Manage this page

Citations, last 5 years: 1 371
Works, last 5 years: 135
h-index: 48
Scientists listed: 3
Grants since 2016: 11

Grants received

2025–2026 · research · R41

Repurposing Pyrvinium as an Inhalation Therapy for Idiopathic Pulmonary Fibrosis

James Cardelli · Aeolis Research (United States) · funded by National Institutes of Health

$309.4k

2022–2024 · research · R41

Chemosensitization of Glioblastoma by Propentofylline

Nhan L Tran · Aeolis Research (United States) · funded by National Institutes of Health

$400k

2020–2022 · research · R41

Oleocanthal functional food products for breast cancer recurrence control

Khalid A El Sayed · Aeolis Research (United States) · funded by National Institutes of Health

$400k

2020–2022 · research · R41

Oleocanthal functional food products for breast cancer recurrence control

Khalid A El Sayed · Aeolis Research (United States) · funded by National Institutes of Health

$54.8k

2019–2021 · research · R43

Evaluation of a selective PPAR-gamma agonist for treatment of Alzheimer’s Disease

James Cardelli · Aeolis Research (United States) · funded by National Institutes of Health

$103kPeroxisome Proliferator-Activated Receptors

2019–2024 · research · R42

Evaluation of a dual PPAR agonist for treatment of Alzheimer's disease

James Cardelli · Aeolis Research (United States) · funded by National Institutes of Health

$1.7MPeroxisome Proliferator-Activated Receptors

2019–2020 · research · R43

Evaluation of a selective PPAR-gamma agonist for treatment of Alzheimer’s Disease

James Cardelli · Aeolis Research (United States) · funded by National Institutes of Health

$347kPeroxisome Proliferator-Activated Receptors

2019–2025 · research · R42

Evaluation of a dual PPAR agonist for treatment of Alzheimer's disease

James Cardelli · Aeolis Research (United States) · funded by National Institutes of Health

$805.8kPeroxisome Proliferator-Activated Receptors

2019–2025 · research · R42

Evaluation of a dual PPAR agonist for treatment of Alzheimer's disease

James Cardelli · Aeolis Research (United States) · funded by National Institutes of Health

$249.8kPeroxisome Proliferator-Activated Receptors

2018–2020 · research · R43

Evaluation of oral oleocanthal to prevent and/or treat Alzheimer’s disease and related dementias

James Cardelli · Aeolis Research (United States) · funded by National Institutes of Health

$269.6k

2018–2021 · research · R43

Evaluation of oral oleocanthal to prevent and/or treat Alzheimer’s disease and related dementias

James Cardelli · Aeolis Research (United States) · funded by National Institutes of Health

$67k